Market Analysis and Insights: Global Prenatal and Newborn Genetic Testing Market
The global Prenatal and Newborn Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Prenatal and Newborn Genetic Testing Scope and Market Size
Prenatal and Newborn Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prenatal and Newborn Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom

Market segment by Type, the product can be split into

Array-Comparative Genetic Hybridization (aCGH)
Fluorescence In-Situ Hybridization (FISH)
Polymerase Chain Reaction (PCR)

Market segment by Application, split into

Hospitals
Diagnostic Organization
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India